The past 15 months haven’t been easy for growth stock investors. The Nasdaq Composite index has fallen a disappointing 25% since the beginning of 2022, making this an unusually long bear market.
You don’t need an economics degree to see that every bear market in history has been wiped away by subsequent recoveries. We don’t know when the next recovery period will begin, but buying top growth stocks now, while their prices are depressed, gives you a better-than-average chance to realize market-beating gains down the road.
Over the past year, Vertex Pharmaceuticals (NASDAQ: VRTX) climbed 23%, while the Nasdaq Composite tumbled 15% lower. Shares of the medical technology company DexCom (NASDAQ:…
